A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and ...

Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute, tapping into SCRI ...

When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical clinical ...

Children’s National Hospital is poised to recruit patients for a new clinical trial that will take on an old, implacable foe: children’s solid tumors. Little progress has been made in 30 years.

Clinical trials are widely accepted as the way to progress toward establishing new standards in cancer therapies while simultaneously offering affordable, state-of-the-art care. But few people ...

AI enhances breast cancer care by improving mammography accuracy, reducing false negatives, and aiding in clinical trial enrollment and design. AI-driven digital patient profiling reduces placebo use ...

New bilingual database allows patients to search by cancer type, contains details about eligibility, treatment, location and ...

Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible. Molecular ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...

Can psilocybin help people with advanced cancer who are coping with anxiety, depression, fear of death, and loss of hope?